- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Adrianne Appel2024-07-26T13:36:00
Admera Health agreed to pay more than $5.5 million to resolve allegations first brought by two whistleblowers that it paid kickbacks to third-party contractors, the Department of Justice (DOJ) said.
New Jersey-based Admera will pay nearly $5.4 million to settle alleged violations of the False Claims Act and Anti-Kickback Statute and nearly $148,000 to individual states over reimbursed claims to Medicare, the DOJ said in a press release Wednesday.
The case resolves claims first brought under the qui tam provisions of the False Claims Act by Sunil Wadwa and Ken Newton, co-founders of Financial Halo–a former third-party marketer of Admera. The whistleblowers will receive more than $862,000, the DOJ said.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
A pharmaceutical company and its chief executive have agreed to pay $47 million to settle allegations first brought by whistleblowers, that the company paid kickbacks and filed false claims, the Department of Justice said.
Walgreens agreed to pay nearly $107 million to resolve allegations, first brought by two whisteblowers, that it improperly billed federal healthcare programs for prescriptions that were never picked up or delivered.
Home health and hospice agency Intrepid USA agreed to pay $3.8 million to settle allegations, first brought by four whistleblowers, that its facilities billed Medicare for services patients were not qualified to receive, according to the Department of Justice.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
